Goto D - Search Results

1

Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy.

Kawanaka M, Nishino K, Nakamura J, Oka T, Urata N, Goto D, Suehiro M, Kawamoto H, Kudo M, Yamada G. Kawanaka M, et al. Among authors: goto d. Liver Cancer. 2014 Mar;3(1):41-52. doi: 10.1159/000343857. Liver Cancer. 2014. PMID: 24804176 Free PMC article.

2

[Clinical characteristics of non-alcoholic steatohepatitis (NASH) patients who progressed from F3 stage fibrosis to cirrhotic NASH].

Kawanaka M, Oka T, Urata N, Kimura T, Nakamura J, Goto D, Yamato R, Nishino K, Suehiro M, Kawamoto H, Yamada G. Kawanaka M, et al. Among authors: goto d. Nihon Shokakibyo Gakkai Zasshi. 2012 Dec;109(12):2042-8. Nihon Shokakibyo Gakkai Zasshi. 2012. PMID: 23221052 Japanese.

3

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study.

Kawanaka M, Nishino K, Nakamura J, Suehiro M, Goto D, Urata N, Oka T, Kawamoto H, Nakamura H, Yodoi J, Hino K, Yamada G. Kawanaka M, et al. Among authors: goto d. Hepat Med. 2013 Mar 4;5:11-6. doi: 10.2147/HMER.S41258. eCollection 2013. Hepat Med. 2013. PMID: 24695939 Free PMC article.

4

Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease.

Kawanaka M, Nishino K, Nakamura J, Urata N, Oka T, Goto D, Suehiro M, Kawamoto H, Yamada G. Kawanaka M, et al. Among authors: goto d. Ann Hepatol. 2015 Nov-Dec;14(6):837-44. doi: 10.5604/16652681.1171767. Ann Hepatol. 2015. PMID: 26436355 Free article.

5

Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma.

Ochi N, Goto D, Yamane H, Yamagishi T, Honda Y, Monobe Y, Kawamoto H, Takigawa N. Ochi N, et al. Among authors: goto d. Onco Targets Ther. 2014 Oct 7;7:1847-50. doi: 10.2147/OTT.S68757. eCollection 2014. Onco Targets Ther. 2014. PMID: 25336976 Free PMC article.

6

The intra-conduit release method is useful for avoiding migration of metallic stents during EUS-guided hepaticogastrostomy (with video).

Uchida D, Kawamoto H, Kato H, Goto D, Tomoda T, Matsumoto K, Yamamoto N, Horiguchi S, Tsutsumi K, Okada H. Uchida D, et al. Among authors: goto d. J Med Ultrason (2001). 2018 Jul;45(3):399-403. doi: 10.1007/s10396-017-0846-x. Epub 2017 Dec 13. J Med Ultrason (2001). 2018. PMID: 29235065

7

Outcome of self-expandable metallic stent deployment in patients with malignant gastroduodenal outlet obstruction and Niti-S and WallFlex comparison: a multicenter retrospective clinical study.

Kato H, Kawamoto H, Matsumoto K, Moriyama I, Kamada H, Tsutsumi K, Goto D, Fukuba N, Kato K, Sonoyama H, Isomoto H, Okada H. Kato H, et al. Among authors: goto d. J Dig Dis. 2016 Aug;17(8):518-525. doi: 10.1111/1751-2980.12377. J Dig Dis. 2016. PMID: 27383654

8

Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease: Multicenter clinical experience (with videos).

Ogura T, Takenaka M, Shiomi H, Goto D, Tamura T, Hisa T, Kato H, Nishioka N, Minaga K, Masuda A, Onoyama T, Kudo M, Higuchi K, Kitano M. Ogura T, et al. Among authors: goto d. Endosc Ultrasound. 2019 Nov-Dec;8(6):398-403. doi: 10.4103/eus.eus_45_19. Endosc Ultrasound. 2019. PMID: 31552912 Free PMC article.

9

Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction.

Yamao K, Kitano M, Chiba Y, Ogura T, Eguchi T, Moriyama I, Yamashita Y, Kato H, Kayahara T, Hoki N, Okabe Y, Shiomi H, Nakai Y, Kushiyama Y, Fujimoto Y, Hayashi S, Bamba S, Kudo Y, Azemoto N, Ueki T, Uza N, Asada M, Matsumoto K, Nebiki H, Takihara H, Noguchi C, Kamada H, Nakase K, Goto D, Sanuki T, Koga T, Hashimoto S, Nishikiori H, Serikawa M, Hanada K, Hirao K, Ohana M, Kazuyuki I, Kato T, Yoshida M, Kawamoto H. Yamao K, et al. Among authors: goto d. Gut. 2021 Jul;70(7):1244-1252. doi: 10.1136/gutjnl-2020-320775. Epub 2020 Nov 22. Gut. 2021. PMID: 33223499 Free PMC article. Clinical Trial.

10

Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.

Sugihara M, Tsutsumi A, Suzuki E, Wakamatsu E, Suzuki T, Ogishima H, Hayashi T, Chino Y, Ishii W, Mamura M, Goto D, Matsumoto I, Ito S, Sumida T. Sugihara M, et al. Among authors: goto d. Arthritis Rheum. 2007 Jul;56(7):2160-9. doi: 10.1002/art.22724. Arthritis Rheum. 2007. PMID: 17599736 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters